We thank the editors for giving us an opportunity to respond to this letter. We also thank the authors of the letter for their interest in our article and their kind comments. The authors seem to imply that oncoplastic breast surgery (OBS) is restricted to breast-conserving surgery for large tumours. However, OBS also refers to the techniques of skin-sparing mastectomy and immediate reconstruction and breast-conserving surgery for small tumours.
We would most respectfully disagree with the assertion that oncoplastic breast conserving surgery has a negative impact on patient outcome in terms of survival and morbidity. There is robust evidence that oncoplastic breast conserving surgery provides excellent disease-free survival (96% at 7 years) [1] . Oncoplastic breast conserving surgery presents a viable alternative to standard wide local excision which is shown to be associated with a high re-excision rate (12.9% vs. 6.5%) [2] . The incidence of local control and survival has been shown to be similar for locally advanced breast cancer between oncoplastic and non-oncoplastic breast conserving surgery. These results have been replicated in large series with long follow-up with high (88%) patient satisfaction with the aesthetic outcome [3, 4] .
The authors of the letter state that oncoplastic breast procedures are associated with a higher rate of complications. The analyses from the American College of Surgeons National Surgical Quality Improvement Program database confirm that the use of OBS does not confer an increased risk of surgical complications, despite the longer operative time [5] . Thus, the role of adequate training, informed patient consent and appropriate patient selection cannot be over-emphasised. We assert that we do not advocate attainment of aesthetic excellence at the expense of compromise of oncological safety. Our article purports to say that it is possible to attain both these objectives in a vast majority of patients with surgical techniques, planning, and training.
